发明名称 |
Dexmedetomidine premix formulation |
摘要 |
The presently disclosed subject matter relates to pharmaceutical compositions comprising dexmedetomidine or a pharmaceutically acceptable salt thereof wherein the composition is formulated as a liquid for parenteral administration to a subject, and wherein the composition is disposed within a sealed container as a premixture. The pharmaceutical compositions can be used, for example, in perioperative care of a patient or for sedation. |
申请公布号 |
US9616049(B2) |
申请公布日期 |
2017.04.11 |
申请号 |
US201615058602 |
申请日期 |
2016.03.02 |
申请人 |
HOSPIRA, INC. |
发明人 |
Roychowdhury Priyanka;Cedergren Robert A. |
分类号 |
A61K9/08;A61K31/4164;A61K31/4174;A61K47/02;A61L2/00 |
主分类号 |
A61K9/08 |
代理机构 |
Baker Botts L.L.P. |
代理人 |
Baker Botts L.L.P. |
主权项 |
1. A ready to use liquid pharmaceutical composition for parenteral administration to a subject, comprising dexmedetomidine or a pharmaceutically acceptable salt thereof at a concentration of about 0.005 to about 50 μg/mL disposed within a sealed glass container, wherein the liquid pharmaceutical composition has a pH of about 2 to about 10. |
地址 |
Lake Forest IL US |